SCHEMBL7998422

SCHEMBL7998422

CCCOP(=O)(OCCC)C(SCC)(C(=O)O)P(=O)(OCCC)OCCC

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7882579 0.91 ALDH1A1 (0.33) ALDH1A1MEN1KMT2A
SCHEMBL8002514 0.90 CYP3A4 (0.42) ALDH1A1LMNA
SCHEMBL7882571 0.85 TSHR (0.34) ALDH1A1
SCHEMBL7989602 0.79
SCHEMBL7990056 0.75 CTSA (0.30)
SCHEMBL17882068 0.66 MEN1 (0.33) ALDH1A1MEN1KMT2A
SCHEMBL17860873 0.66 LMNA (0.33) ALDH1A1MEN1KMT2ALMNA
SCHEMBL3899262 0.66 MEN1 (0.37) ALDH1A1MEN1KMT2A
SCHEMBL814692 0.66 MEN1 (0.37) ALDH1A1MEN1KMT2A
SCHEMBL7882574 0.66 MVD (0.38) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0944635-A4 DIPHOSPHONATE THERAPEUTIC COMPOUNDS ELIZANOR BIOPHARMACEUTICALS IN (US) 2000-07-05 EP claimed
EP-0944635-A1 DIPHOSPHONATE THERAPEUTIC COMPOUNDS Elizanor Biopharmaceuticals, Inc. (US) 1999-09-29 EP claimed
WO-1998015560-A1 DIPHOSPHONATE THERAPEUTIC COMPOUNDS ELIZANOR BIOPHARMACEUTICALS, INC. (US) 1998-04-16 WO claimed
EP-0944635-A4 DIPHOSPHONATE THERAPEUTIC COMPOUNDS ELIZANOR BIOPHARMACEUTICALS IN (US) 2000-07-05 EP disclosed
EP-0944635-A1 DIPHOSPHONATE THERAPEUTIC COMPOUNDS Elizanor Biopharmaceuticals, Inc. (US) 1999-09-29 EP disclosed
WO-1998015560-A1 DIPHOSPHONATE THERAPEUTIC COMPOUNDS ELIZANOR BIOPHARMACEUTICALS, INC. (US) 1998-04-16 WO disclosed